Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging

Radiotherapy and Oncology

Volumn 88, Issue 1, 2008, Pages 127-134

  Kershaw, Lucy E ^a   Logue, John P ^b   Hutchinson, Charles E ^a   Clarke, Noel W ^b   Buckley, David L ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Dynamic contrast enhanced MRI; Microvascular perfusion; Microvascular permeability; Prostate; Radiotherapy treatment response

Indexed keywords

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BLOOD VOLUME; CAPILLARY PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; HORMONAL THERAPY; HUMAN; MALE; MATHEMATICAL COMPUTING; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; PROSTATE TUMOR; TUMOR BLOOD FLOW;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 45849142217     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.02.018     Document Type: Article

References (43)

1. Ries LAG, Harkins D, Krapcho M, et al., editors. SEER Cancer Statistics Review, 1975-2003. Bethesda, USA: National Cancer Institute; 2006.
2. Gosselaar C., Roobol M.J., Roemeling S., van der Kwast T.H., and Schroder F.H. Screening for prostate cancer at low PSA range: the impact of digital rectal examination on tumor incidence and tumor characteristics. Prostate 67 (2007) 154-161
3. Schroder F.H., van der Maas P., Beemsterboer P., et al. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 90 (1998) 1817-1823
4. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 1997;37:1035-1041.
5. Prestidge B.R., Hoak D.C., Grimm P.D., et al. Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer. Int J Radiat Oncol Biol Phys 37 (1997) 31-39
6. Magi-Galluzzi C., Sanderson H., and Epstein J.I. Atypia in nonneoplastic prostate glands after radiotherapy for prostate cancer: duration of atypia and relation to type of radiotherapy. Am J Surg Pathol 27 (2003) 206-212
7. Crook J.M., Bahadur Y.A., Robertson S.J., Perry G.A., and Esche B.A. Evaluation of radiation effect, tumor differentiation, and prostate specific antigen staining in sequential prostate biopsies after external beam radiotherapy for patients with prostate carcinoma. Cancer 79 (1997) 81-89
8. Laking G.R., West C., Buckley D.L., Matthews J., and Price P.M. Imaging vascular physiology to monitor cancer treatment. Crit Rev Oncol Hematol 58 (2006) 95-113
9. Sahani D.V., Kalva S.P., Hamberg L.M., et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology 234 (2005) 785-792
10. de Lussanet Q.G., Backes W.H., Griffioen A.W., et al. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1309-1315
11. Mayr N.A., Yuh W.T., Magnotta V.A., et al. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. Int J Radiat Oncol Biol Phys 36 (1996) 623-633
12. Harvey C.J., Blomley M.J., Dawson P., et al. Functional CT imaging of the acute hyperemic response to radiation therapy of the prostate gland: early experience. J Comput Assist Tomogr 25 (2001) 43-49
13. Hoskin P.J., Saunders M.I., Goodchild K., et al. Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. Br J Radiol 72 (1999) 1093-1098
14. de Vries A., Griebel J., Kremser C., et al. Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy. Radiology 217 (2000) 385-391
15. Lyng H., Vorren A.O., Sundfor K., et al. Intra- and intertumor heterogeneity in blood perfusion of human cervical cancer before treatment and after radiotherapy. Int J Cancer 96 (2001) 182-190
16. Gaudin P.B., Zelefsky M.J., Leibel S.A., Fuks Z., and Reuter V.E. Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues. Am J Surg Pathol 23 (1999) 1021-1031
17. Sheaff M.T., and Baithun S.I. Effects of radiation on the normal prostate gland. Histopathology 30 (1997) 341-348
18. Bostwick D.G., Egbert B.M., and Fajardo L.F. Radiation injury of the normal and neoplastic prostate. Am J Surg Pathol 6 (1982) 541-551
19. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
20. Byhart R.W., and Moss W.T. The heart and blood vessels. In: Cox J.D. (Ed). Moss' radiation oncology. 7th ed. (1994), Mosby, St. Louis, Missouri 307-319
21. * contrast-enhanced dynamic MR imaging. J Magn Reson Imaging 11 (2000) 575-585
22. Brookes J.A., Redpath T.W., Gilbert F.J., Murray A.D., and Staff R.T. Accuracy of T1 measurement in dynamic contrast-enhanced breast MRI using two- and three-dimensional variable flip angle fast low-angle shot. J Magn Reson Imaging 9 (1999) 163-171
23. Liney G.P., Turnbull L.W., Lowry M., et al. In vivo quantification of citrate concentration and water T2 relaxation time of the pathologic prostate gland using 1H MRS and MRI. Magn Reson Imaging 15 (1997) 1177-1186
24. Wefer A.E., Hricak H., Vigneron D.B., et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 164 (2000) 400-404
25. Buckley D.L., Roberts C., Parker G.J., Logue J.P., and Hutchinson C.E. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging-initial experience. Radiology 233 (2004) 709-715
26. Ikonen S., Kivisaari L., Vehmas T., et al. Optimal timing of post-biopsy MR imaging of the prostate. Acta Radiol 42 (2001) 70-73
27. Livsey J.E., Cowan R.A., Wylie J.P., et al. Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis. Int J Radiat Oncol Biol Phys 57 (2003) 1254-1259
28. Kuban D., Thames H., Levy L., et al. Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?. Int J Radiat Oncol Biol Phys 61 (2005) 409-414
29. Cheng D., and Tempany C.M. MR imaging of the prostate and bladder. Semin Ultrasound CT MR 19 (1998) 67-89
30. Maio A., and Rifkin M.D. Magnetic resonance imaging of prostate cancer: update. Top Magn Reson Imaging 7 (1995) 54-68
31. St Lawrence K.S., and Lee T.Y. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cereb Blood Flow Metab 18 (1998) 1365-1377
32. Tofts P.S., Brix G., Buckley D.L., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
33. Koh T.S., Zeman V., Darko J., et al. The inclusion of capillary distribution in the adiabatic tissue homogeneity model of blood flow. Phys Med Biol 46 (2001) 1519-1538
34. Kershaw L.E., and Buckley D.L. Precision in measurements of perfusion and microvascular permeability with T(1)-weighted dynamic contrast-enhanced MRI. Magn Reson Med 56 (2006) 986-992
35. Chan T.W., and Kressel H.Y. Prostate and seminal vesicles after irradiation: MR appearance. J Magn Reson Imaging 1 (1991) 503-511
36. Padhani A.R., MacVicar A.D., Gapinski C.J., et al. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology 218 (2001) 365-374
37. Toma H., Nakamura R., Onitsuka S., Goya N., and Nakazawa H. Effect of endocrine treatment on prostatic blood flow in patients with prostatic adenocarcinoma. J Urol 140 (1988) 91-95
38. Smith D.M., and Murphy W.M. Histologic changes in prostate carcinomas treated with leuprolide (luteinizing hormone-releasing hormone effect). Distinction from poor tumor differentiation. Cancer 73 (1994) 1472-1477
39. Moss' radiation oncology. 7th ed. St. Louis, Missouri: Mosby; 1994.
40. Ceelen W., Smeets P., Backes W., et al. Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model. Int J Radiat Oncol Biol Phys 64 (2006) 1188-1196
41. Noworolski SM, Chen AP, Vigneron DB, Kurhanewicz J. Assessment of prostatic ductal volume using combined dynamic contrast-enhanced MRI and diffusion MRI. In: International society of magnetic resonance in medicine, vol. 11. 2003. p. 1464.
42. Rouviere O., Valette O., Grivolat S., et al. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor-correlation with biopsy findings. Urology 63 (2004) 922-927
43. Blomlie V., Rofstad E.K., Talle K., et al. Incidence of radiation-induced insufficiency fractures of the female pelvis: evaluation with MR imaging. AJR Am J Roentgenol 167 (1996) 1205-1210